BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22819427)

  • 1. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival.
    Hasin T; Topilsky Y; Kremers WK; Boilson BA; Schirger JA; Edwards BS; Clavell AL; Rodeheffer RJ; Frantz RP; Joyce L; Daly R; Stulak JM; Kushwaha SS; Park SJ; Pereira NL
    Am J Cardiol; 2012 Nov; 110(9):1322-8. PubMed ID: 22819427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Physical Capacity 6 Months After Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis From the ELEVATE Registry.
    Gustafsson F; Mirza KK; Pya Y; Shaw S; Diegeler A; Netuka I; Lavee J; Garbade J; Morshuis M; Heatley J; Saeed D; Potapov E; Schmitto JD; Zimpfer D;
    J Card Fail; 2020 Jul; 26(7):580-587. PubMed ID: 32417377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.
    Dunlay SM; Allison TG; Pereira NL
    J Card Fail; 2014 Aug; 20(8):548-54. PubMed ID: 24893345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.
    Martins RP; Leclercq C; Bourenane H; Auffret V; Boulé S; Loobuyck V; Dambrin C; Mondoly P; Sacher F; Bordachar P; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Kerneis C; Ghodhbane W; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Pierre B; Bourguignon T; Eschallier R; D'Ostrevy N; Bories MC; Jouan J; Vanhuyse F; Sadoul N; Flécher E; Galand V
    Heart Rhythm; 2019 Oct; 16(10):1506-1512. PubMed ID: 31255846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.
    Di Salvo TG; Mathier M; Semigran MJ; Dec GW
    J Am Coll Cardiol; 1995 Apr; 25(5):1143-53. PubMed ID: 7897128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of 6-minute walk test in stable outpatients with heart failure.
    Arslan S; Erol MK; Gundogdu F; Sevimli S; Aksakal E; Senocak H; Alp N
    Tex Heart Inst J; 2007; 34(2):166-9. PubMed ID: 17622362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.
    Ferreira JP; Metra M; Anker SD; Dickstein K; Lang CC; Ng L; Samani NJ; Cleland JG; van Veldhuisen DJ; Voors AA; Zannad F
    Eur J Heart Fail; 2019 Feb; 21(2):218-226. PubMed ID: 30600578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting factors of peak and submaximal exercise capacity in LVAD patients.
    Fresiello L; Jacobs S; Timmermans P; Buys R; Hornikx M; Goetschalckx K; Droogne W; Meyns B
    PLoS One; 2020; 15(7):e0235684. PubMed ID: 32645710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
    Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
    JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
    Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L
    Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Asleh R; Alnsasra H; Daly RC; Schettle SD; Briasoulis A; Taher R; Dunlay SM; Stulak JM; Behfar A; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Kushwaha SS
    J Am Heart Assoc; 2019 Nov; 8(22):e013108. PubMed ID: 31701791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Function Testing and Outcomes after Left Ventricular Assist Device Implantation.
    Raheja S; Nemeh H; Williams C; Tita C; Selektor Y; Chamogeorgiakis T; Lanfear D
    Heart Surg Forum; 2019 May; 22(3):E202-E206. PubMed ID: 31237543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.
    Song HK; Gelow JM; Mudd J; Chien C; Tibayan FA; Hollifield K; Naftel D; Kirklin J
    Ann Thorac Surg; 2016 Jun; 101(6):2168-74. PubMed ID: 27139368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.